HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
about
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisStress and neurodevelopmental processes in the emergence of psychosisPartial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.The influence of stress at puberty on mood and learning: role of the α4βδ GABAA receptorNegative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders.HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis.Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Symptom Data.Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress.Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.Anxiety in youth at clinical high risk for psychosis.Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis.Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.Friends interventions in psychosis: a narrative review and call to action.Role of cortisol in patients at risk for psychosis mental state and psychopathological correlates: A systematic review.Altering the course of schizophrenia: progress and perspectives.Prefrontal Cortex Dysfunction Increases Susceptibility to Schizophrenia-Like Changes Induced by Adolescent Stress Exposure.Stress Sensitivity and Psychotic Experiences in 39 Low- and Middle-Income Countries.Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.Prenatal immune activation interacts with stress and corticosterone exposure later in life to modulate N-methyl-D-aspartate receptor synaptic function and plasticity.Clinical high risk for psychosis in children and adolescents: a systematic review.The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.Developmental timing and critical windows for the treatment of psychiatric disorders.Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis.Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.Cognitive impairment and cortisol levels in first-episode schizophrenia patients.Increased pituitary volume in subjects at risk for psychosis and patients with first-episode schizophrenia.
P2860
Q26748778-1B9ED493-BABC-4A39-91D0-2EF0416A6E5AQ26830600-5371DA95-7A9E-4C20-BE2C-6F4037F66A65Q30400033-50B1EA9F-20F3-4368-AFD3-2ACC309083F9Q30430187-72D024C9-E326-42FC-9250-E1FB0481A7BBQ31114703-94E152C9-95D3-4254-A780-7D71A355FDE5Q33451672-6A689682-BD8E-4271-B54E-3CAB144874C2Q33453744-EDF71243-92D9-43B2-BDC8-76A116B956E6Q35624912-9A37E32D-258E-4C33-981F-5186855A7526Q36296028-590A39FD-0959-4F1A-B149-7A5E42BE6317Q36332243-C1C8453E-0DCE-44FD-85B3-950B18AF4424Q36573111-51D19361-AE91-48D2-A667-C67511D4F752Q36702534-2DE531D7-9651-4FF5-A04B-D3CD957B6502Q36736182-80F75FC6-D329-41BD-8AAE-AA8B9D9C69C2Q36998471-BB012D64-06FD-4B9F-8C10-AAF2346B4782Q37017300-E65371F3-737E-42B4-9C59-5F2DE72634AFQ37026255-649E9090-D35C-4AAB-AC89-BF6E5B144CEDQ37103318-05485591-CC46-40F0-9469-B06C06360D9FQ37622280-B0248FAA-DF7C-48FF-A2F9-D3650AEB9098Q38072452-6EC67F4D-1275-4E5F-828B-83FAEB64DA8BQ38170139-73B20E12-BDDA-4CD8-BC9A-0B50CD6C542EQ38240577-52FE34DD-4FC1-417F-BB97-B9F6A05E7582Q38272093-A7B554D1-3CDA-4175-9319-6F0F5524644FQ38759421-23C6E8A7-4FA8-4AC8-8DF4-AC3396AEDC3CQ39076734-16FE14DB-69B1-462B-A1F6-552696FA0774Q39826129-7445EEB5-D4CB-4910-B8CD-868DE45D6D84Q41656821-B55B84A3-C224-4AE0-BE7B-7D071D188197Q41725359-AA89F97B-A38D-4E7E-82D2-54DA7FB06316Q43943643-1FC4B96A-6F19-4057-99C9-233E8BAE0CD1Q47621148-DE5B57C3-45BA-414C-86CE-855BF441AEF7Q47832927-01073B6F-C197-482A-AFB0-51E7FC137C32Q47895125-3B1495A7-0A37-44E8-9DC2-BEA2A534B1FEQ47903993-5D707A41-924C-414E-818D-9154F1B80CE0Q48036597-3E6D2AEC-01DA-4840-8B63-8F230A9E70F5Q48667025-F9322F56-6371-4CFC-807B-ECC2ED807E95Q48951628-DEDFAC49-6A2E-4DEB-A142-0B2B3D5D553B
P2860
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@en
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@nl
type
label
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@en
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@nl
prefLabel
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@en
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@nl
P2093
P2860
P1476
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.
@en
P2093
B Cornblatt
C M Corcoran
D Malaspina
D McLaughlin
P2860
P304
P356
10.1016/J.SCHRES.2011.11.035
P407
P577
2012-01-09T00:00:00Z